SAN FRANCISCO (TheStreet)-29-annual J.P. Morgan Healthcare Conference kicks off this morning with key biotech presentations Celgene from (CELG ), Vertex pharmaceuticals (VRTX ) Dendreon, (DNDN ) and Human Genome Sciences (HGSI ).
Here's how this live blog happens to (hopefully) work: I will be posting news, updates and analysis throughout the day, live from the presentation rooms and separation (Q&A) session. [How can I do this, the APP Will ask you., literally Use the blog APP iPhone. bound in publication system of TheStreet--quite pure.]
This J.P. Morgan confab blog will be similar to real-time coverage of FDA Advisory panels with one big difference: expect more breaks between my postings today, since I will be moving the Conference and waiting for companies to present throughout the day. I will do my best to provide constant coverage, but of course that I am somewhat at the mercy of the AT&T network and my ability to type on my iPhone while weaving through crowds and listening to biotech executives speak.
Your best bet is to check again on the blog several times throughout the day.
Similar to my previous live blogs I'd like to keep today's coverage interactive, so feel free to ping me with comments and questions. I will publish and will respond to as many comments and questions.
Here is my planned schedule for the day, is subject to change, as always. (All times Eastern):
11 am: Celgene
12: 30 pm: vertex pharmaceuticals
1 pm: Onyx pharmaceuticals (ONXX )
2: 30 p.m.: Dendreon
4: 30 pm: Amylin Pharmaceuticals (AMLN )
5: 30 pm: AMAG pharmaceuticals (AMAG )
6: 30 pm: Human Genome Sciences
-Written by Adam Fojer?ajn in Boston.
> To contact the writer of this article, click here: Adam Fojer?ajn.
> To follow at Twitter, http://twitter.com/adamfeuerstein go.
> Submit news tip, please send an e-mail to tips@thestreet.com:.
沒有留言:
張貼留言